» Articles » PMID: 39695093

Increased Herpes Simplex Virus 1, Toxoplasma Gondii and Cytomegalovirus Antibody Concentrations in Severe Mental Illness

Abstract

Infections with Cytomegalovirus (CMV), Herpes simplex virus 1 (HSV1) and Toxoplasma gondii (TG) have been implicated in severe mental illness. All three pathogens have high seroprevalence in the human population, are neurotropic and establish a persistent infection. We hypothesized that exposed (seropositive) patients with severe mental illness would show higher immunoglobulin G (IgG) concentrations than exposed healthy controls (HC). We included 765 patients with severe mental illness (schizophrenia n = 515, bipolar disorder n = 250) and 541 HC. CMV, HSV1 and TG IgG seropositivity and concentrations were measured with immunoassays (seropositivity: CMV, n = 447 patients vs. 296 HC; HSV1, n = 355 vs. 238; and TG, n = 159 vs. 126). Among seropositive participants, patients had higher HSV1 (p < 0.001) and TG (p = 0.003) IgG concentrations than HC. Stratifying by diagnosis, both schizophrenia (p = 0.001) and bipolar disorder (p = 0.001) had higher HSV1 IgG concentrations, while schizophrenia only had higher TG (p = 0.009) and CMV (p = 0.045) IgG concentrations than HC. In SZ, higher HSV1 IgG concentrations were associated with higher psychotic (p = 0.030) and manic (p = 0.008) symptom scores, but only among CMV- or TG-infected patients which suggests synergistic effects. Among all participants, HSV1 IgG concentrations were inversely associated with interleukin-18 (p < 0.001) and positively associated with high-sensitivity C-reactive protein (p = 0.002) and B cell-activating factor (p = 0.004), possibly indicating T cell exhaustion, enhanced inflammation, and increased B-cell response, respectively. Patients with severe mental illness exhibit a heightened immune system response to HSV1, TG, and CMV infections suggesting immune system dysfunction and/or a more severe infection. For HSV1, higher IgG concentrations were linked to a greater clinical burden.

References
1.
Galobardes B, Shaw M, Lawlor D, Lynch J, Davey Smith G . Indicators of socioeconomic position (part 1). J Epidemiol Community Health. 2005; 60(1):7-12. PMC: 2465546. DOI: 10.1136/jech.2004.023531. View

2.
Tanaka T, Matsuda T, Hayes L, Yang S, Rodriguez K, Severance E . Infection and inflammation in schizophrenia and bipolar disorder. Neurosci Res. 2016; 115:59-63. DOI: 10.1016/j.neures.2016.11.002. View

3.
Iglesias-Escudero M, Moro-Garcia M, Marcos-Fernandez R, Garcia-Torre A, Alvarez-Arguelles M, Suarez-Fernandez M . Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients. PLoS One. 2018; 13(4):e0194789. PMC: 5895001. DOI: 10.1371/journal.pone.0194789. View

4.
Bohn M, Babor T, Kranzler H . The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995; 56(4):423-32. DOI: 10.15288/jsa.1995.56.423. View

5.
Andreasen N, Pressler M, Nopoulos P, Miller D, Ho B . Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2009; 67(3):255-62. PMC: 3677042. DOI: 10.1016/j.biopsych.2009.08.040. View